Literature DB >> 3968910

Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment.

P P Karpawich, C P Bush, J R Antillon, J J Amato, M L Marbey, K C Agarwal.   

Abstract

The effectiveness of 19 modified Blalock-Taussig shunts performed with expanded polytetrafluoroethylene was evaluated clinically and by cardiac catheterization with angiography 4 to 24 months after operation. Fifteen patients underwent operation in infancy. Conduit diameters included 4 mm (nine cases), 5 mm (eight cases), and 6 mm (two cases) sizes. Two of the 4 mm conduits failed after 1 year following implantation. The remaining 17 shunts (89%) remained widely patent. In patients with patent shunts, the oxygen saturation values were significantly improved from the preoperative values. Two children demonstrated associated subclavian artery occlusion distal to the graft anastomosis. There were no deaths. Thirteen children underwent more complete elective cardiac repair 5 to 24 months later. Although the modified Blalock-Taussig procedure is an effective short-term alternative to the classic Blalock-Taussig shunt, the effectiveness of the 4 mm diameter conduit may be limited without postoperative anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968910

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt.

Authors:  Mehmet Küçük; Rahmi Özdemir; Mustafa Karaçelik; Önder Doksöz; Cem Karadeniz; Yılmaz Yozgat; Timur Meşe; Nejat Sarıosmanoğlu
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

2.  Modified versus classical Blalock-Taussig shunts for congenital cyanotic heart diseases: a comparison of long-term results.

Authors:  K Sakai; K Goh; T Gohda; M Sakuma; O Matsunami; K Yasuda; T Tanabe; T Murakami
Journal:  Jpn J Surg       Date:  1987-11

3.  Endovascular stent implantation as a primary method of treatment for blocked modified Blalock‒Taussig shunt.

Authors:  Praneet Lale; Neeraj Aggarwal; Mridul Agarwal; Reena Khantwal Joshi; Raja Joshi; B S Vivek
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

4.  The use of anticoagulation in pediatric cardiac disease.

Authors:  J R Boris; M A Harris
Journal:  Images Paediatr Cardiol       Date:  2003-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.